On Mar. 30, 2020, the Institute for Molecular Medicine in Finland (FIMM) announced it had launched a COVID-19 host genetics initiative. The COVID-19 host genetics initiative brings together the human genetics community to generate, share and analyze data to learn the genetic determinants of COVID-19 susceptibility, severity and outcomes. Such discoveries could help to generate hypotheses for drug repurposing, identify individuals at unusually high or low risk, and contribute to global knowledge of the biology of SARS-CoV-2 infection and disease. As of April 9, more than 100 studies participating and samples from for example Northern Italy, California and Finland had been collected.